Danaher (DHR) Expected to Announce Earnings on Wednesday

Danaher (NYSE:DHR) is expected to issue its Q4 2025 results before the market opens on Wednesday, January 28th. Analysts expect Danaher to post earnings of $2.14 per share and revenue of $6.7861 billion for the quarter. Individuals may visit the the company’s upcoming Q4 2025 earning results page for the latest details on the call scheduled for Wednesday, January 28, 2026 at 8:00 AM ET.

Danaher Stock Performance

NYSE DHR opened at $236.70 on Tuesday. Danaher has a 1-year low of $171.00 and a 1-year high of $258.23. The company has a 50 day moving average of $230.59 and a 200-day moving average of $213.48. The company has a current ratio of 1.52, a quick ratio of 1.10 and a debt-to-equity ratio of 0.33. The firm has a market cap of $167.19 billion, a price-to-earnings ratio of 48.80, a PEG ratio of 3.58 and a beta of 0.89.

Danaher Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, January 30th. Investors of record on Friday, December 26th will be issued a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a yield of 0.5%. The ex-dividend date of this dividend is Friday, December 26th. Danaher’s dividend payout ratio (DPR) is currently 26.39%.

Insider Buying and Selling

In other Danaher news, SVP Georgeann Couchara sold 5,174 shares of the company’s stock in a transaction on Monday, November 10th. The shares were sold at an average price of $210.42, for a total transaction of $1,088,713.08. Following the completion of the sale, the senior vice president owned 2,625 shares in the company, valued at approximately $552,352.50. The trade was a 66.34% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, SVP Brian W. Ellis sold 21,776 shares of the firm’s stock in a transaction on Wednesday, November 12th. The stock was sold at an average price of $219.23, for a total value of $4,773,952.48. Following the completion of the transaction, the senior vice president owned 14,553 shares in the company, valued at $3,190,454.19. This represents a 59.94% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 30,248 shares of company stock valued at $6,609,663 over the last ninety days. Insiders own 11.20% of the company’s stock.

Hedge Funds Weigh In On Danaher

A number of hedge funds and other institutional investors have recently made changes to their positions in the company. Invesco Ltd. increased its position in shares of Danaher by 23.7% in the 3rd quarter. Invesco Ltd. now owns 3,813,128 shares of the conglomerate’s stock valued at $755,991,000 after buying an additional 729,597 shares in the last quarter. Viking Global Investors LP grew its stake in Danaher by 543.9% in the second quarter. Viking Global Investors LP now owns 2,907,515 shares of the conglomerate’s stock valued at $574,351,000 after acquiring an additional 2,455,994 shares during the period. Raymond James Financial Inc. increased its holdings in shares of Danaher by 8.1% in the second quarter. Raymond James Financial Inc. now owns 1,704,914 shares of the conglomerate’s stock worth $336,789,000 after acquiring an additional 127,993 shares in the last quarter. AQR Capital Management LLC raised its position in shares of Danaher by 65.1% during the third quarter. AQR Capital Management LLC now owns 1,464,336 shares of the conglomerate’s stock worth $276,276,000 after purchasing an additional 577,462 shares during the period. Finally, California State Teachers Retirement System lifted its holdings in shares of Danaher by 0.6% during the 3rd quarter. California State Teachers Retirement System now owns 1,033,134 shares of the conglomerate’s stock valued at $204,829,000 after purchasing an additional 6,577 shares in the last quarter. 79.05% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several analysts have recently commented on the company. JPMorgan Chase & Co. increased their target price on Danaher from $260.00 to $270.00 and gave the stock an “overweight” rating in a report on Wednesday, October 22nd. Wells Fargo & Company increased their price objective on shares of Danaher from $230.00 to $240.00 and gave the stock an “equal weight” rating in a report on Monday, December 15th. Redburn Partners set a $220.00 price objective on shares of Danaher in a research report on Wednesday, October 8th. Rothschild & Co Redburn reiterated a “neutral” rating and set a $220.00 target price (down from $245.00) on shares of Danaher in a research report on Wednesday, October 8th. Finally, KeyCorp reissued an “overweight” rating on shares of Danaher in a research note on Thursday, December 18th. Twenty investment analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $252.09.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.